The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Crohn’s Disease Treatment Market Expected To Scale Between 2026 And 2030?
The Crohn’s disease treatment market size has observed substantial growth in recent years. It is projected to increase from $13.1 billion in 2025 to $13.99 billion in 2026, at a compound annual growth rate (CAGR) of 6.8%. The expansion during the historic period can be attributed to an uptick in Crohn’s disease prevalence, a greater understanding of inflammatory bowel diseases, the enlargement of hospital pharmacy networks, the availability of conventional anti-inflammatory drugs, and advancements in diagnostic capabilities.
The Crohn’s disease treatment market size is anticipated to demonstrate robust expansion over the coming years. It is set to increase to $18.86 billion by 2030, achieving a compound annual growth rate (CAGR) of 7.8%. This projected growth within the forecast period can be attributed to factors such as the expanding pipeline of biologics and small molecules, a rising demand for personalized treatment, increased online pharmacy penetration, growing healthcare expenditure in emerging markets, and a focus on long-term disease management. Significant trends during this period encompass the increasing adoption of biologic therapies, a shift towards early and aggressive treatment approaches, a greater emphasis on steroid-sparing regimens, the advancement of oral small-molecule therapies, and the widening reach of online and specialty pharmacy channels.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10852&type=smp
Which Primary Drivers Are Impacting The Crohn’s Disease Treatment Market Growth?
The Crohn’s disease treatment market is anticipated to expand due to the growing occurrence of inflammatory bowel disorders. These disorders are a category of chronic illnesses characterized by inflammation of the gastrointestinal tract, which can lead to inflammation and harm anywhere along the digestive system, extending from the mouth to the anus. Treatments for Crohn’s disease aim to reduce intestinal inflammation, avert symptom flare-ups, and sustain remission. For example, data from September 2023, provided by the US government organization, the National Center for Biotechnology Information, indicated a comparable rise in the prevalence of both Crohn’s disease and ulcerative colitis. In 2023, inflammatory bowel disease was estimated to affect 825 cases per 100,000 people, specifically 410 for Crohn’s disease and 414 for ulcerative colitis and IBD-u. Consequently, this increasing prevalence of inflammatory bowel disorders is driving the growth within the Crohn’s disease treatment market.
How Is The Crohn’s Disease Treatment Market Organized By Segment Classification?
The crohn’s disease treatment market covered in this report is segmented –
1) By Drug Type: Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators, Other Drug Types
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By Application: Neuropathic Pain, Fibromyalgia, Chronic Back Pain, Arthritic Pain, Migraine Post-Operative Pain, Cancer Pain, Other Applications
Subsegments:
1) By Antibiotics: Metronidazole, Ciprofloxacin, Other Antibiotics
2) By Amino Salicylates: Mesalamine, Sulfasalazine, Other Amino Salicylates
3) By Corticosteroids: Prednisone, Budesonide, Other Corticosteroids
4) By Immunomodulators: Azathioprine, Methotrexate, Mercaptopurine
5) By Other Drug Types: Biologics, Small Molecules, Other Treatments
What Trends Are Influencing The Evolution Of The Crohn’s Disease Treatment Market?
Prominent companies in the crohn’s disease treatment market are developing and gaining approval for novel medications, including biosimilar ustekinumab. This initiative aims to deliver more effective and readily available treatment choices for patients, thereby enhancing their outcomes and quality of life. Biosimilar ustekinumab is defined as a biologic drug that closely resembles the original ustekinumab, which is a monoclonal antibody utilized for managing autoimmune conditions. As an example, Sandoz International GmbH, a pharmaceutical company based in Switzerland, introduced Pyzchiva (ustekinumab) throughout Europe in July 2024. This launch established it as the initial ustekinumab biosimilar offered in every strength, notably a 130 mg vial designated for Crohn’s disease. The product is prescribed for adults and children aged over six who suffer from plaque psoriasis, psoriatic arthritis, and Crohn’s disease. Its introduction bolsters Sandoz’s immunology portfolio and concurrently seeks to broaden availability of economical treatments for chronic inflammatory disease.
Who Are The Industry Participants Involved In The Crohn’s Disease Treatment Market?
Major companies operating in the crohn’s disease treatment market are AbbVie Inc., Janssen Pharmaceuticals, Takeda Pharmaceutical Company Limited, Bristol-Myers Squibb Company, Galapagos NV, Teva Pharmaceutical Industries Ltd., Mylan N.V., Glenmark Pharmaceuticals, Tillotts Pharma AG, Dr. Falk Pharma GmbH, Shire Pharmaceuticals, Salix Pharmaceuticals, Prometheus Laboratories Inc., Pfizer Inc., Novartis AG, Sanofi S.A., Eli Lilly and Company, Boehringer Ingelheim GmbH, Arena Pharmaceuticals Inc., F. Hoffmann-La Roche Ltd.
Get The Full Crohn’s Disease Treatment Market Report:
https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report
Which Region Is The Leading Market For The Crohn’s Disease Treatment Market?
North America was the largest region in the global Crohn’s disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the crohn’s disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Crohn’s Disease Treatment Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report
Browse Through More Reports Similar to the Global Crohn’s Disease Treatment Market 2026, By The Business Research Company
Crohns Disease Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report
Crohns Disease Cd Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/crohns-disease-cd-treatment-global-market-report
Inflammatory Bowel Disease Treatment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model